ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT04508790

Public ClinicalTrials.gov record NCT04508790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial of Leflunomide, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Study identification

NCT ID
NCT04508790
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
City of Hope Medical Center
Other
Enrollment
29 participants

Conditions and interventions

Interventions

  • Dexamethasone Drug
  • Leflunomide Drug
  • Pomalidomide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2020
Primary completion
Feb 13, 2027
Completion
Feb 13, 2027
Last update posted
May 3, 2026

2020 – 2027

United States locations

U.S. sites
8
U.S. states
1
U.S. cities
8
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010 Recruiting
City of Hope at Seacliff Huntington Beach California 92648 Recruiting
City of Hope at Antelope Valley Lancaster California 93534 Recruiting
City of Hope at Long Beach Elm Long Beach California 90813 Recruiting
City of Hope at Newport Beach Fashion Island Newport Beach California 92660 Recruiting
City of Hope at South Pasadena South Pasadena California 91030 Recruiting
City of Hope at South Bay Torrance California 90503 Recruiting
City of Hope at Upland Upland California 91786 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04508790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04508790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →